Your browser doesn't support javascript.
loading
Persistent, refractory, and biphasic anaphylaxis: A multidisciplinary Delphi study.
Dribin, Timothy E; Sampson, Hugh A; Camargo, Carlos A; Brousseau, David C; Spergel, Jonathan M; Neuman, Mark I; Shaker, Marcus; Campbell, Ronna L; Michelson, Kenneth A; Rudders, Susan A; Assa'ad, Amal H; Risma, Kimberly A; Castells, Mariana; Schneider, Lynda C; Wang, Julie; Lee, Juhee; Mistry, Rakesh D; Vyles, David; Vaughn, Lisa M; Schumacher, Daniel J; Witry, John K; Viswanathan, Shiv; Page, Erica M; Schnadower, David.
Afiliação
  • Dribin TE; Division of Emergency Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio. Electronic address: Timothy.Dribin@cchmc.org.
  • Sampson HA; Division of Allergy and Immunology, Icahn School of Medicine at Mount Sinai, New York.
  • Camargo CA; Department of Emergency Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Mass.
  • Brousseau DC; Section of Pediatric Emergency Medicine, Department of Pediatrics, Medical College of Wisconsin, Milwaukee, Wis.
  • Spergel JM; Division of Allergy and Immunology, Children's Hospital of Philadelphia, Perelman School of Medicine at University of Pennsylvania, Philadelphia, Pa.
  • Neuman MI; Division of Emergency Medicine, Boston Children's Hospital, Boston, Mass; Department of Pediatrics, Harvard Medical School, Boston, Mass.
  • Shaker M; Dartmouth Geisel School of Medicine, Hanover, NH; Dartmouth-Hitchcock Medical Center, Hanover, NH.
  • Campbell RL; Department of Emergency Medicine, Mayo Clinic, Rochester, Minn.
  • Michelson KA; Division of Emergency Medicine, Boston Children's Hospital, Boston, Mass; Department of Pediatrics, Harvard Medical School, Boston, Mass.
  • Rudders SA; Division of Immunology, Boston Children's Hospital, Boston, Mass; Department of Pediatrics, Harvard Medical School, Boston, Mass.
  • Assa'ad AH; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio; Division of Allergy and Immunology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
  • Risma KA; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio; Division of Allergy and Immunology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
  • Castells M; Division of Allergy and Clinical Immunology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Mass.
  • Schneider LC; Division of Immunology, Boston Children's Hospital, Boston, Mass; Department of Pediatrics, Harvard Medical School, Boston, Mass.
  • Wang J; Division of Allergy and Immunology, Icahn School of Medicine at Mount Sinai, New York.
  • Lee J; Division of Allergy and Immunology, Children's Hospital of Philadelphia, Perelman School of Medicine at University of Pennsylvania, Philadelphia, Pa.
  • Mistry RD; Section of Emergency Medicine, Department of Pediatrics, Children's Hospital Colorado, Aurora, Colo.
  • Vyles D; Section of Pediatric Emergency Medicine, Department of Pediatrics, Medical College of Wisconsin, Milwaukee, Wis.
  • Vaughn LM; Cincinnati Children's Hospital Medical Center and the University of Cincinnati College of Medicine, Cincinnati, Ohio.
  • Schumacher DJ; Division of Emergency Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio.
  • Witry JK; Division of Emergency Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
  • Viswanathan S; Division of Emergency Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
  • Page EM; University of Cincinnati, Cincinnati, Ohio.
  • Schnadower D; Division of Emergency Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio.
J Allergy Clin Immunol ; 146(5): 1089-1096, 2020 11.
Article em En | MEDLINE | ID: mdl-32853640
ABSTRACT

BACKGROUND:

The use of inconsistent definitions for anaphylaxis outcomes limits our understanding of the natural history and epidemiology of anaphylaxis, hindering clinical practice and research efforts.

OBJECTIVE:

Our aim was to develop consensus definitions for clinically relevant anaphylaxis outcomes by utilizing a multidisciplinary group of clinical and research experts in anaphylaxis.

METHODS:

Using Delphi methodology, we developed agenda topics and drafted questions to review during monthly conference calls. Through online surveys, a 19-member panel consisting of experts in allergy and/or immunology and emergency medicine rated their level of agreement with the appropriateness of statements on a scale of 1 to 9. A median value of 1.0 to 3.4 was considered inappropriate, a median value of 3.5 to 6.9 was considered uncertain, and a median value of 7.0 to 9.0 was considered appropriate. A disagreement index was then calculated, with values less than 1.0 categorized as "consensus reached." If consensus was not reached after the initial survey, subsequent surveys incorporating the aggregate de-identified responses from prior surveys were sent to panel members. This process was repeated until consensus was reached or 4 survey rounds had been completed, after which the question was categorized as "no consensus reached."

RESULTS:

The panel developed outcome definitions for persistent, refractory, and biphasic anaphylaxis, as well as for persistent and biphasic nonanaphylactic reactions. There was also consensus among panel members regarding the need to develop an anaphylaxis severity grading system.

CONCLUSION:

Dissemination and application of these definitions in clinical care and research will help standardize the terminology used to describe anaphylaxis outcomes and serve as the foundation for future research, including research aimed at development of an anaphylaxis severity grading system.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Anafilaxia Tipo de estudo: Guideline / Prognostic_studies Limite: Humans País/Região como assunto: America do norte Idioma: En Revista: J Allergy Clin Immunol Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Anafilaxia Tipo de estudo: Guideline / Prognostic_studies Limite: Humans País/Região como assunto: America do norte Idioma: En Revista: J Allergy Clin Immunol Ano de publicação: 2020 Tipo de documento: Article
...